(GD) General Dynamics - Overview
Stock: Business Jets, Submarines, Combat Vehicles, IT Solutions, Unmanned Vehicles
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.91% |
| Yield on Cost 5y | 4.19% |
| Yield CAGR 5y | 6.11% |
| Payout Consistency | 79.7% |
| Payout Ratio | 38.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.0% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.59 |
| Alpha | 31.34 |
| Character TTM | |
|---|---|
| Beta | 0.563 |
| Beta Downside | 0.463 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.55% |
| CAGR/Max DD | 0.81 |
Description: GD General Dynamics January 29, 2026
General Dynamics (NYSE:GD) is a diversified aerospace and defense contractor organized into four operating segments: Aerospace (business-jet sales and related services), Marine Systems (nuclear-powered submarines, surface combatants, and commercial vessels), Combat Systems (land combat vehicles, weapons, and sustainment programs), and Technologies (IT, cyber, AI/ML, cloud, ISR, and unmanned undersea platforms). The company, founded in 1899 and based in Reston, Virginia, serves U.S. military, allied governments, and commercial customers worldwide.
Key recent metrics (FY 2025): revenue $39.2 billion (up 5% YoY), adjusted EPS $7.45, and an order backlog of roughly $130 billion, of which $45 billion is tied to submarine and surface-ship contracts. Defense spending in the United States is projected to grow ~2% in FY 2026, driven by the Navy’s 2025-2029 shipbuilding plan and increased funding for land-combat modernization-both core growth engines for GD’s Marine and Combat Systems segments. Meanwhile, the business-jet market has shown a 12% YoY rise in deliveries in 2025, supporting the Aerospace segment’s revenue outlook.
For a deeper quantitative view, you might explore GD’s valuation metrics and scenario analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 4.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.20 > 1.0 |
| NWC/Revenue: 14.18% < 20% (prev 13.75%; Δ 0.43% < -1%) |
| CFO/TA 0.09 > 3% & CFO 5.12b > Net Income 4.21b |
| Net Debt (7.46b) to EBITDA (6.10b): 1.22 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (273.9m) vs 12m ago -1.08% < -2% |
| Gross Margin: 15.13% > 18% (prev 0.15%; Δ 1498 % > 0.5%) |
| Asset Turnover: 92.90% > 50% (prev 85.39%; Δ 7.51% > 0%) |
| Interest Coverage Ratio: 17.25 > 6 (EBITDA TTM 6.10b / Interest Expense TTM 314.0m) |
Altman Z'' 5.47
| A: 0.13 (Total Current Assets 24.25b - Total Current Liabilities 16.80b) / Total Assets 57.25b |
| B: 0.77 (Retained Earnings 44.08b / Total Assets 57.25b) |
| C: 0.10 (EBIT TTM 5.42b / Avg Total Assets 56.56b) |
| D: 1.39 (Book Value of Equity 44.08b / Total Liabilities 31.63b) |
| Altman-Z'' Score: 5.47 = AAA |
Beneish M -3.06
| DSRI: 0.87 (Receivables 10.79b/11.22b, Revenue 52.55b/47.72b) |
| GMI: 1.02 (GM 15.13% / 15.43%) |
| AQI: 0.99 (AQ_t 0.45 / AQ_t-1 0.45) |
| SGI: 1.10 (Revenue 52.55b / 47.72b) |
| TATA: -0.02 (NI 4.21b - CFO 5.12b) / TA 57.25b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of GD shares?
Over the past week, the price has changed by +2.56%, over one month by +0.23%, over three months by +6.24% and over the past year by +43.63%.
Is GD a buy, sell or hold?
- StrongBuy: 6
- Buy: 4
- Hold: 14
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the GD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 394.8 | 9.6% |
| Analysts Target Price | 394.8 | 9.6% |
| ValueRay Target Price | 445.3 | 23.7% |
GD Fundamental Data Overview February 07, 2026
P/E Forward = 21.0084
P/S = 1.8527
P/B = 3.7152
P/EG = 2.4825
Revenue TTM = 52.55b USD
EBIT TTM = 5.42b USD
EBITDA TTM = 6.10b USD
Long Term Debt = 7.01b USD (from longTermDebt, last quarter)
Short Term Debt = 1.30b USD (from shortTermDebt, last quarter)
Debt = 9.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.46b USD (from netDebt column, last quarter)
Enterprise Value = 104.82b USD (97.36b + Debt 9.79b - CCE 2.33b)
Interest Coverage Ratio = 17.25 (Ebit TTM 5.42b / Interest Expense TTM 314.0m)
EV/FCF = 26.48x (Enterprise Value 104.82b / FCF TTM 3.96b)
FCF Yield = 3.78% (FCF TTM 3.96b / Enterprise Value 104.82b)
FCF Margin = 7.53% (FCF TTM 3.96b / Revenue TTM 52.55b)
Net Margin = 8.01% (Net Income TTM 4.21b / Revenue TTM 52.55b)
Gross Margin = 15.13% ((Revenue TTM 52.55b - Cost of Revenue TTM 44.60b) / Revenue TTM)
Gross Margin QoQ = 14.89% (prev 15.25%)
Tobins Q-Ratio = 1.83 (Enterprise Value 104.82b / Total Assets 57.25b)
Interest Expense / Debt = 0.64% (Interest Expense 63.0m / Debt 9.79b)
Taxrate = 18.30% (256.0m / 1.40b)
NOPAT = 4.43b (EBIT 5.42b * (1 - 18.30%))
Current Ratio = 1.44 (Total Current Assets 24.25b / Total Current Liabilities 16.80b)
Debt / Equity = 0.38 (Debt 9.79b / totalStockholderEquity, last quarter 25.62b)
Debt / EBITDA = 1.22 (Net Debt 7.46b / EBITDA 6.10b)
Debt / FCF = 1.88 (Net Debt 7.46b / FCF TTM 3.96b)
Total Stockholder Equity = 23.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.44% (Net Income 4.21b / Total Assets 57.25b)
RoE = 17.57% (Net Income TTM 4.21b / Total Stockholder Equity 23.97b)
RoCE = 17.49% (EBIT 5.42b / Capital Employed (Equity 23.97b + L.T.Debt 7.01b))
RoIC = 13.60% (NOPAT 4.43b / Invested Capital 32.55b)
WACC = 7.31% (E(97.36b)/V(107.15b) * Re(7.99%) + D(9.79b)/V(107.15b) * Rd(0.64%) * (1-Tc(0.18)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.36%
[DCF Debug] Terminal Value 77.83% ; FCFF base≈3.65b ; Y1≈3.01b ; Y5≈2.17b
Fair Price DCF = 141.8 (EV 45.80b - Net Debt 7.46b = Equity 38.35b / Shares 270.4m; r=7.31% [WACC]; 5y FCF grow -21.06% → 2.90% )
EPS Correlation: 76.18 | EPS CAGR: 13.31% | SUE: 0.44 | # QB: 0
Revenue Correlation: 94.20 | Revenue CAGR: 12.03% | SUE: 2.46 | # QB: 5
EPS next Quarter (2026-03-31): EPS=3.66 | Chg30d=-0.177 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=16.27 | Chg30d=-1.020 | Revisions Net=-11 | Growth EPS=+5.3% | Growth Revenue=+4.0%
EPS next Year (2027-12-31): EPS=18.26 | Chg30d=-0.780 | Revisions Net=-8 | Growth EPS=+12.2% | Growth Revenue=+4.6%